Kenvue Inc., the owner of Tylenol and Neutrogena, reported sales that trailed estimates after its skin health and beauty ...

(Reuters) -Neutrogena-owner Kenvue's third-quarter sales fell short of expectations on Thursday, marking the fifth ...

Hello, and welcome to the Kenvue third quarter 2024 earnings conference call. All lines have been placed on mute to prevent ...

Kenvue reported third-quarter sales slightly below Wall Street expectations on Thursday, hurt by weak sales of its skin ...

Kenvue reported third-quarter sales marginally below Wall Street estimates on Thursday, hurt by weakness in its skin health ...

Looking for the latest stock opportunities in December 2024? We have you covered. Click to read our top stock picks to ...

Headlines,Institutional investors increase their stakes in Kenvue Inc.,XML Financial LLC acquires significant position in ...

Kenvue announced financial results for the fiscal third quarter which ended September 29, 2024. Net sales in Q3 reached ...

Jefferies has recently initiated Kenvue Inc (KVUE) stock to Buy rating, as announced on September 24, 2024, according to Finviz. Earlier, on September 24, 2024, RBC Capital Mkts had reduced the stock ...

Kenvue misses quarterly sales estimates as skincare sales decline Kenvue said it now expects annual net sales to grow closer to the lower end of its forecast of 1% to 3% growth. The consumer ...

The consumer health company posted revenue of $3.9 billion in the period, falling short of Street forecasts. Five analysts surveyed by Zacks expected $3.92 billion. Kenvue expects full-year earnings ...